Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of General Internal Medicine
|
August 17, 2014
Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial
Karen L Margolis, Lisa Palermo, Eric Vittinghoff, et al.
Clinical Nephrology
|
May 26, 2020
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
Kristen L Nowak, Michel Chonchol, Anna Jovanovich, et al.
Diabetologia
|
July 3, 2014
Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial
Zubin Punthakee, Michael E Miller, Debra L Simmons, et al.
Journal of Clinical Lipidology
|
August 16, 2017
Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial
Radmila Lyubarova, Jennifer G Robinson, Michael Miller, et al.
The American Journal of Medicine
|
April 3, 2016
Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH
Ronald B Goldberg, Vera A Bittner, Richard L Dunbar, et al.
Diabetes Care
|
February 25, 2011
Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial
Roger T Anderson, K M Venkat Narayan, Patricia Feeney, et al.
Diabetes Care
|
May 16, 2012
Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial
Patrick J O'Connor, K M Venkat Narayan, Roger Anderson, et al.
Diabetes Care
|
December 4, 2013
Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial
Peter E Linz, Laura C Lovato, Robert P Byington, et al.
Canadian Journal of Kidney Health and Disease
|
March 9, 2017
A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy
Srinivasan Beddhu, Rebecca Filipowicz, Bin Wang, et al.
American Journal of Hypertension
|
April 13, 2019
Serum Sodium and Pulse Pressure in SPRINT
Kristen L Nowak, Michel Chonchol, Anna Jovanovich, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of General Internal Medicine
|
August 17, 2014
Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial
Karen L Margolis, Lisa Palermo, Eric Vittinghoff, et al.
Clinical Nephrology
|
May 26, 2020
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
Kristen L Nowak, Michel Chonchol, Anna Jovanovich, et al.
Diabetologia
|
July 3, 2014
Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial
Zubin Punthakee, Michael E Miller, Debra L Simmons, et al.
Journal of Clinical Lipidology
|
August 16, 2017
Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial
Radmila Lyubarova, Jennifer G Robinson, Michael Miller, et al.
The American Journal of Medicine
|
April 3, 2016
Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH
Ronald B Goldberg, Vera A Bittner, Richard L Dunbar, et al.
Diabetes Care
|
February 25, 2011
Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial
Roger T Anderson, K M Venkat Narayan, Patricia Feeney, et al.
Diabetes Care
|
May 16, 2012
Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial
Patrick J O'Connor, K M Venkat Narayan, Roger Anderson, et al.
Diabetes Care
|
December 4, 2013
Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial
Peter E Linz, Laura C Lovato, Robert P Byington, et al.
Canadian Journal of Kidney Health and Disease
|
March 9, 2017
A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy
Srinivasan Beddhu, Rebecca Filipowicz, Bin Wang, et al.
American Journal of Hypertension
|
April 13, 2019
Serum Sodium and Pulse Pressure in SPRINT
Kristen L Nowak, Michel Chonchol, Anna Jovanovich, et al.
Page
of 4